DoseSpot

Private

Dedham, MassachusettsHealthcare & Life Scienceshttps://dosespot.com/

Last Round

M&A

Mar 2, 2026

Total Funding Raised

$25,000

Company Overview

DoseSpot is a healthcare technology company that provides e-prescribing, insurance verification, and revenue cycle management software solutions for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Vertical SaaS, Telemedicine, Compliance

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

ePrescribingelectronic prescribingelectronic prescribing of controlled substancese-prescribing APIEPCSelectronic prior authorizationePAEHR integrationreal-time prescription benefitRTPBprescription softwarehealthtech APItelehealth softwareembedded UIdigital health infrastructuree-prescribing widget

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DoseSpot Comps

Public and private peers based on sector, stage, and business model.

DoseSpot comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DoseSpot Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Mar 2, 2026
Growth Equity	Jan 26, 2022
Grant	May 1, 2010

View all Funding Rounds

Key People

Founding team and executive leadership

Tosin Adesegha

Chief Financial Officer

Executive Team

Julian Herbert

Chief Product Officer

Executive Team

DoseSpot Investors

Notable investors and investment history

DoseSpot investors
Investor	Rounds
Providence Strategic Growth	M&A, Growth Equity
UPMC Enterprises	M&A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 26, 2022
Providence Strategic Growth led the round.

View all signals

DoseSpot Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DoseSpot Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DoseSpot's valuation, stock price, and market status.

Firmographic Details

HeadquartersDedham, Massachusetts

Employee Range77

Year Founded2009

Last FundingMar 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.